Navigation Links
Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
Date:1/9/2008

MINNEAPOLIS, Jan. 9 /PRNewswire/ -- Nonin Medical, Inc.'s CEO, Gary Tschautscher received the highly regarded Industry Best Practices Award for CEO of 2007 for the North American Patient Monitoring Industry from Frost & Sullivan. Frost & Sullivan recognizes outstanding industry achievements in regional and global markets and the Awards are recognized worldwide by the media, the investment community and end-user markets. The global growth consulting company honored Tschautscher for his pioneering vision and strategic affiliations to bring Nonin's robust, portable and easy-to-use pulse oximetry technology to more people and applications worldwide.

"As a result of its strategic efforts in ongoing product innovation and support activities, Nonin has doubled its market share and achieved worldwide coverage, penetrating alternate care markets as well as leading the sleep diagnostic market," reported Frost and Sullivan. With well over 1 million oximeters sold worldwide, Nonin's oximeters have opened up a whole new direction in patient care in both acute care and alternate care markets. A number of Nonin's innovative "firsts" include the world's first self-contained fingertip oximeter, the first low power handheld oximeter and the first Bluetooth(R) Wireless Oximeter. Because of their accuracy, small size and portability,

Tschautscher and his management team have approached physiological monitoring with vigor, providing the most extensive line of pulse oximetry, capnography, software and sensors to both the human and veterinary markets. Tschautscher's boundless enthusiasm begins with his true care for the patient. "We are making a difference in how patients are cared for and that makes it all worthwhile. Our ultimate goal is to simplify patient monitoring and keep our focus on the future and how patient care is evolving."

About Nonin Medical, Inc. - http://www.nonin.com

Minneapolis-based Nonin Medical, Inc., a privately owned company specializing in the design and manufacture of physiological monitoring solutions, distributes its branded and 90+ OEM products to health and medical professionals in more than 125 countries. Since 1986, Nonin has developed a broad product line of pulse oximeters, capnographs, sensors, accessories and software for use by medical professionals. Its industry-leading capabilities in signal processing, sensor design and an innovative combination of features not available in competitive products are the foundation of its leadership in innovation.

About Frost & Sullivan - http://www.frost.com

Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.awards.frost.com.


'/>"/>
SOURCE Nonin Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Noninvasive tests for cirrhosis may help to avoid liver biopsy
2. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
3. Nonin Medical is Honored With Niche Supplier Award from Amerinet
4. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
5. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
6. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
7. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
8. Medical, Behavioral Woes Can Drive Dogs to Bite
9. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
10. Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers Compensation and Leave Administration Services for Employers
11. Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... ... the day, adults often find themselves reaching for a cup of coffee, an energy drink, ... for instead is a cup of Matcha green tea. Matcha is a premium green tea ... harvested from early June to mid-July, when the leaves are the most tender. , ...
(Date:5/31/2016)... ... May 31, 2016 , ... St. ... (Healthconnect) regional health information exchange, which enables physicians at SJMC’s two hospital campuses, ... from other participating organizations in the exchange. SJMC’s membership in the health information ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... DDL, Inc. ... American Association for Laboratory Accreditation (A2LA) to include ISO 594-1 and ISO 594-2 testing ... means of achieving a leak-free connection between two medical devices (e.g. a syringe and ...
(Date:5/31/2016)... ... May 31, 2016 , ... The successful implementation of “lean ... laboratories as well. However, laboratories have different challenges compared to manufacturing environments. , ... in the lab, METTLER TOLEDO has developed the Lean Lab Checklist . This ...
(Date:5/31/2016)... ... May 31, 2016 , ... In his latest ... personality traits in humans. Using presidential candidate Donald Trump as an example, Kalsi ... , “AstroNumerology is not about adding numbers up,” says Kalsi. “It is about ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... and Orphan Diseases, today announced that President & CEO Gerald ... SeeThru Equity MicroCap Conference   Where: ... , NY When: Tuesday, May 31 st , ... Where: Grand Hyatt Hotel, 109 East 42 nd St, ...
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
Breaking Medicine Technology: